With a cancer diagnosis, early detection means better outcomes. It means hope. But when it comes to breast cancer, more than half of women have a reduced opportunity for an early, life-saving diagnosis.
That's why we're developing Syantra DX: a blood test to detect breast cancer. It’s a revolutionary, rapid, economical approach to breast cancer screening that's accurate regardless of the test recipient's family history, age or tissue density.
We’re working to improve the odds.
That's why we're developing Syantra DX: a blood test to detect breast cancer. It’s a revolutionary, rapid, economical approach to breast cancer screening that's accurate regardless of the test recipient's family history, age or tissue density.
We’re working to improve the odds.
Location: Canada, Alberta, Calgary
Employees: 11-50
Phone: +1 877-331-0516
Total raised: $4.9M
Investors 4
| Date | Name | Website |
| - | Innovate C... | innovateca... |
| 21.03.2022 | Plug and P... | plugandpla... |
| 23.01.2022 | Accelerate... | accelerate... |
| - | Thin Air L... | thinairlab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.09.2024 | Series A | $4.9M | - |
Mentions in press and media 4
| Date | Title | Description |
| 13.09.2024 | Syantra's Bold Leap: $4.9 Million for Cancer Detection Revolution | In the heart of Calgary, a biotechnology company is making waves. Syantra, Inc. has secured CAD$4.9 million in Series A-1 funding. This is not just a financial boost; it’s a lifeline for innovation. The funding round was led by CG Wealth Ma... |
| 11.09.2024 | Syantra Raises CAD$4.9M in Series A-1 Funding | Syantra, a Calgary, Canada-based precision biotechnology company, raised CAD$4.9M in Series A-1 funding. The round was led by CG Wealth Management, with participation from existing investors. The company intends to use the funds to expand o... |
| 11.09.2024 | Syantra Secures $4.9 Million in Series A-1 Funding; Adds Dr. Rick Mangat to Board of Directors | Syantra, Inc. secures new funding for expansion and commercialization of its pioneering platform for early detection of cancer CALGARY, AB, Sept. 11, 2024 /PRNewswire/ - Syantra, Inc., a privately held precision biotechnology company pionee... |
| - | Syantra | “Syantra Inc. is a precision healthcare company changing the way cancer is detected and treated, starting with breast cancer. Learn more about Syantra DX™ Breast Cancer. A blood test for breast cancer that's easy, convenient and accurate.”... |